Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease

被引:0
作者
Kuhnowski F. [1 ]
Terriou L. [1 ]
Magro L. [1 ]
Jouet J.-P. [1 ]
Yakoub-Agha I. [1 ]
机构
[1] Service des Maladies du Sang, UAM Allogreffes de CSH, CHRU, Lille
关键词
Imatinib; Tacrolimus; Chronic Myeloid Leukaemia; Mycophenolate Mofetil; Busulfan;
D O I
10.2165/00003495-200666002-00009
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:29 / 31
页数:2
相关论文
共 50 条
[41]   Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients [J].
Hummel, Manfred ;
Yonan, Nizar ;
Ross, Heather ;
Miller, Leslie W. ;
Sechaud, Romain ;
Balez, Sebastien ;
Koelle, Ernst Ulrich ;
Gerosa, Gino .
CLINICAL TRANSPLANTATION, 2007, 21 (01) :18-23
[42]   Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis [J].
Czock, David ;
Rasche, Franz Maximilian ;
Carius, Alexander ;
Glander, Petra ;
Budde, Klemens ;
Bauer, Steffen ;
Keller, Frieder ;
von Mueller, Lutz .
JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (07) :850-859
[43]   Enteric-Coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Renal Transplant Recipients Experiencing Gastrointestinal Intolerance: A Multicenter, Double-Blind, Randomized Study [J].
Langone, Anthony J. ;
Chan, Laurence ;
Bolin, Paul ;
Cooper, Matthew .
TRANSPLANTATION, 2011, 91 (04) :470-478
[44]   Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease [J].
Marta Krejci ;
Michael Doubek ;
Tomas Buchler ;
Yvona Brychtova ;
Jiri Vorlicek ;
Jiri Mayer .
Annals of Hematology, 2005, 84 :681-685
[45]   Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease [J].
Krejci, M ;
Doubek, M ;
Buehler, T ;
Brychtova, Y ;
Vorlicek, J ;
Mayer, J .
ANNALS OF HEMATOLOGY, 2005, 84 (10) :681-685
[46]   EVALUATION OF TOLERANCE AND SAFETY OF CONVERSION FROM MYCOPHENOLATE MOFETIL TO ENTERIC-COATED MYCOPHENOLIC ACID IN RENAL TRANSPLANT RECIPIENTS [J].
Qiao, L. W. ;
Qu, Q. S. ;
Jiang, X. .
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2017, 31 (01) :141-146
[47]   Mycophenolate Mofetil Is Effective and Well Tolerated in the Treatment of Refractory Acute and Chronic Graft-versus-Host Disease [J].
Akiyoshi Takami ;
Kanako Mochizuki ;
Hirokazu Okumura ;
Hirohito Yamazaki ;
Masahide Yamazaki ;
Yukio Kondo ;
Hidesaku Asakura ;
Shinji Nakao ;
Satsuki Ito ;
Yukio Suga .
International Journal of Hematology, 2006, 83 :80-85
[48]   Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease [J].
Takami, A ;
Mochizuki, K ;
Okumura, H ;
Ito, S ;
Suga, Y ;
Yamazaki, H ;
Yamazaki, M ;
Kondo, Y ;
Asakura, H ;
Nakao, S .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 83 (01) :80-85
[49]   Comparison of mid-term clinical outcome in heart transplantation patients using mycophenolate mofetil vs. enteric-coated mycophenolate sodium [J].
Jeon, Kina ;
Kim, Darae ;
Choi, Jin-Oh ;
Cho, Yang Hyun ;
Sung, Kiick ;
Oh, Jaewon ;
Cho, Hyun Jai ;
Jung, Sung-Ho ;
Lee, Hae-Young ;
Park, Jin Joo ;
Choi, Dong-Ju ;
Kang, Seok-Min ;
Kim, Jae-Joong ;
Jeon, Eun-Seok .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[50]   Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic®) is safe in kidney transplant patients [J].
Salvadori, M. ;
Holzer, H. ;
Civati, G. ;
Sollinger, H. ;
Lien, B. ;
Tomlanovich, S. ;
Bertoni, E. ;
Seifu, Y. ;
Marrast, A. -C. .
CLINICAL NEPHROLOGY, 2006, 66 (02) :112-119